Technical Analysis for IMPL - Impel NeuroPharma, Inc.

Grade Last Price % Change Price Change
F 9.9 -2.94% -0.30
IMPL closed down 2.94 percent on Friday, October 15, 2021, on 37 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong N/A Down Down
Historical IMPL trend table...

Date Alert Name Type % Chg
Multiple of Ten Bearish Other 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -2.94%
Narrow Range Bar Range Contraction -2.94%
NR7 Range Contraction -2.94%
Wide Bands Range Expansion -2.94%
Oversold Stochastic Weakness -2.94%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -5.80%
Multiple of Ten Bullish Other -5.80%
Older End-of-Day Signals for IMPL ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% 1 day ago
Possible NR7 1 day ago
10 DMA Support 1 day ago
Down 2 % 1 day ago
Down 1% 1 day ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Impel NeuroPharma, Inc., a late-stage pharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in the United States. Its lead product candidate is TRUDHESA, an upper nasal formulation of dihydroergotamine for the acute treatment of migraine. The company is also developing INP105, an upper nasal formulation of olanzapine for the acute treatment of agitation and aggression in autism spectrum disorder; and INP107, an upper nasal formulation of carbidopa/levodopa for the treatment of OFF episodes in Parkinson's disease. Impel NeuroPharma, Inc. was incorporated in 2008 and is headquartered in Seattle, Washington.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Drugs Parkinson's Disease Migraine Central Nervous System Disease Treatment Of Migraine Autism Spectrum Disorder Prodrugs Carbidopa L Dopa Catecholamines Combination Drugs Late Stage Pharmaceutical

Is IMPL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 34.75
52 Week Low 6.93
Average Volume 853,661
200-Day Moving Average 0.00
50-Day Moving Average 14.86
20-Day Moving Average 11.59
10-Day Moving Average 10.14
Average True Range 1.48
ADX 28.83
+DI 26.52
-DI 21.20
Chandelier Exit (Long, 3 ATRs) 10.93
Chandelier Exit (Short, 3 ATRs) 13.70
Upper Bollinger Bands 14.67
Lower Bollinger Band 8.50
Percent B (%b) 0.23
BandWidth 53.28
MACD Line -1.41
MACD Signal Line -1.38
MACD Histogram -0.0257
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.12
Resistance 3 (R3) 11.18 10.84 10.91
Resistance 2 (R2) 10.84 10.53 10.81 10.84
Resistance 1 (R1) 10.37 10.34 10.20 10.31 10.78
Pivot Point 10.03 10.03 9.95 10.00 10.03
Support 1 (S1) 9.56 9.72 9.39 9.50 9.02
Support 2 (S2) 9.22 9.53 9.19 8.96
Support 3 (S3) 8.75 9.22 8.89
Support 4 (S4) 8.69